160 related articles for article (PubMed ID: 15975969)
21. Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.
Corden A; Handelman B; Yin H; Cotrim A; Alevizos I; Chiorini JA
Gene Ther; 2017 Apr; 24(4):241-244. PubMed ID: 28150697
[TBL] [Abstract][Full Text] [Related]
22. Decoding the chemokine network that links leukocytes with decidual cells and the trophoblast during early implantation.
Ramhorst R; Grasso E; Paparini D; Hauk V; Gallino L; Calo G; Vota D; Pérez Leirós C
Cell Adh Migr; 2016 Mar; 10(1-2):197-207. PubMed ID: 26891097
[TBL] [Abstract][Full Text] [Related]
23. Sjögren syndrome: what and where are we looking for?
de Paiva CS; Rocha EM
Curr Opin Ophthalmol; 2015 Nov; 26(6):517-25. PubMed ID: 26367089
[TBL] [Abstract][Full Text] [Related]
24. Adult stem cells and tissue engineering strategies for salivary gland regeneration: a review.
Yoo C; Vines JB; Alexander G; Murdock K; Hwang P; Jun HW
Biomater Res; 2014; 18():9. PubMed ID: 26331060
[TBL] [Abstract][Full Text] [Related]
25. IL-17 sequestration via salivary gland gene therapy in a mouse model of Sjogren's syndrome suppresses disease-associated expression of the putative autoantigen Klk1b22.
Wu C; Wang Z; Zourelias L; Thakker H; Passineau MJ
Arthritis Res Ther; 2015 Aug; 17(1):198. PubMed ID: 26245278
[TBL] [Abstract][Full Text] [Related]
26. Advances in salivary gland gene therapy - oral and systemic implications.
Baum BJ; Alevizos I; Chiorini JA; Cotrim AP; Zheng C
Expert Opin Biol Ther; 2015; 15(10):1443-54. PubMed ID: 26149284
[TBL] [Abstract][Full Text] [Related]
27. Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity.
Seoane IV; Tomero E; Martínez C; Garcia-Vicuña R; Juarranz Y; Lamana A; Ocón E; Ortiz AM; Gómez-León N; González-Álvaro I; Gomariz RP
J Mol Neurosci; 2015 Jul; 56(3):577-84. PubMed ID: 25711477
[TBL] [Abstract][Full Text] [Related]
28. Single nucleotide polymorphisms in the 3'UTR of VPAC-1 cooperate in modulating gene expression and impact differently on the interaction with miR525-5p.
Paladini F; Porciello N; Camilli G; Tuncer S; Cocco E; Fiorillo MT; Sorrentino R
PLoS One; 2014; 9(11):e112646. PubMed ID: 25390694
[TBL] [Abstract][Full Text] [Related]
29. Protective Effect of Zengye Decoction () on Submandibular Glands in Nonobese Diabetic Mice.
Li CY; Wu SL; Sun LX; Yan TT; Wang Y
Chin J Integr Med; 2019 Jan; 25(1):45-50. PubMed ID: 25253552
[TBL] [Abstract][Full Text] [Related]
30. Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis.
Hauk V; Fraccaroli L; Grasso E; Eimon A; Ramhorst R; Hubscher O; Pérez Leirós C
Clin Exp Immunol; 2014 Sep; 177(3):662-70. PubMed ID: 24827637
[TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal peptide maintains the nonpathogenic profile of human th17-polarized cells.
Jimeno R; Leceta J; Martínez C; Gutiérrez-Cañas I; Carrión M; Pérez-García S; Garín M; Mellado M; Gomariz RP; Juarranz Y
J Mol Neurosci; 2014 Nov; 54(3):512-25. PubMed ID: 24805298
[TBL] [Abstract][Full Text] [Related]
32. Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren's syndrome.
Lisi S; Sisto M; Ribatti D; D'Amore M; De Lucro R; Frassanito MA; Lorusso L; Vacca A; Lofrumento DD
J Mol Med (Berl); 2014 May; 92(5):523-37. PubMed ID: 24557415
[TBL] [Abstract][Full Text] [Related]
33. VIP modulates IL-22R1 expression and prevents the contribution of rheumatoid synovial fibroblasts to IL-22-mediated joint destruction.
Carrión M; Juarranz Y; Seoane IV; Martínez C; González-Álvaro I; Pablos JL; Gutiérrez-Cañas I; Gomariz RP
J Mol Neurosci; 2014 Jan; 52(1):10-7. PubMed ID: 24254222
[TBL] [Abstract][Full Text] [Related]
34. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.
Delgado M; Ganea D
Amino Acids; 2013 Jul; 45(1):25-39. PubMed ID: 22139413
[TBL] [Abstract][Full Text] [Related]
35. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.
Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP
Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987
[TBL] [Abstract][Full Text] [Related]
36. Gene delivery in salivary glands: from the bench to the clinic.
Samuni Y; Baum BJ
Biochim Biophys Acta; 2011 Nov; 1812(11):1515-21. PubMed ID: 21763423
[TBL] [Abstract][Full Text] [Related]
37. Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Carcamo WC; Chiorini JA; Peck AB
Arthritis Res Ther; 2010; 12(6):R220. PubMed ID: 21182786
[TBL] [Abstract][Full Text] [Related]
38. Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active.
Perez P; Adriaansen J; Goldsmith CM; Zheng C; Baum BJ
Oral Dis; 2011 Jul; 17(5):476-83. PubMed ID: 21122036
[TBL] [Abstract][Full Text] [Related]
39. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Chiorini JA; Peck AB
Lab Invest; 2011 Jan; 91(1):54-62. PubMed ID: 20856230
[TBL] [Abstract][Full Text] [Related]
40. The expression of vasoactive intestinal peptide receptor 1 is negatively modulated by microRNA 525-5p.
Cocco E; Paladini F; Macino G; Fulci V; Fiorillo MT; Sorrentino R
PLoS One; 2010 Aug; 5(8):e12067. PubMed ID: 20706588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
